Bruker Corporation BRKRP
Nov 10, 2026, 9:38 AM EST
- YTD
- +27.44%
- 1 year
- +43.28%
- Market cap
- 10.14B
- Revenue (ttm)
- 3.51B
- Profit margin
- -3.51%
- Dividend
- 15.94
- Ex-dividend date
- Nov 12, 2026
- YTD return
- +27.44%
- 1-year return
- +43.28%
- Volume
- 4
- Avg volume
- 6.07K
- Open
- 461.99
- Previous close
- 484.21
- Day's range
- 461.99 – 487.51
- 52-week range
- 264.30 – 498.45
- Beta
- 1.27
- Earnings date
- Feb 16, 2027
5D +62.41 (+14.80%)
Key statistics
- Enterprise value
- 69.89B
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 32.35
- Dividend yield
- 3.57%
- Payout ratio
- 0.00%
- Revenue growth
- 1.60%
- Free cash flow
- 204.30M
- Total cash
- 119.70M
- Total debt
- 1.74B
- Return on equity
- -4.79%
- Short % of float
- 0.00%
- 50-day average
- 434.84
- 200-day average
- 381.19
Next earnings
Feb 16, 2027
Expected Feb 16, 2027. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 16, 2027 | Dec 30, 2026 | 0.815 | — | — | — |
| Nov 4, 2026 | Sep 30, 2026 | 0.419 | 0.56 | +0.14 | +33.65% |
| Aug 4, 2026 | Jun 30, 2026 | 0.3848 | 0.49 | +0.11 | +27.34% |
| May 6, 2026 | Mar 31, 2026 | 0.2294 | 0.31 | +0.08 | +35.14% |
| Feb 12, 2026 | Dec 31, 2025 | 0.65 | 0.59 | -0.06 | -9.23% |
| Nov 3, 2025 | Sep 30, 2025 | 0.3537 | 0.45 | +0.10 | +27.23% |
About Bruker Corporation
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- bruker.com
News
Your note
Sign in to keep a note on BRKRP — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Aequim Alternative Investments LP | 21.01% | 580,000 | 280.84M | Jun 29, 2026 |
| FMR, LLC | 16.18% | 446,550 | 216.22M | Jun 29, 2026 |
| Shaw D.E. & Co., Inc. | 7.43% | 205,000 | 99.26M | Jun 29, 2026 |
| Franklin Resources, Inc. | 7.25% | 200,000 | 96.84M | Jun 29, 2026 |
| TPG GP A, LLC | 6.36% | 175,500 | 84.98M | Jun 29, 2026 |
| Blackrock Inc. | 6.22% | 171,695 | 83.14M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Preferred and Income Securities ETF | 6.06% | 167,320 | 81.02M | Sep 29, 2026 |
| Franklin Investors Securities TRT-FRANKLIN CONVERTIBLE SECURITIES Fd. | 5.67% | 156,400 | 75.73M | Jul 30, 2026 |
| Fidelity Securities Fund-Fidelity Growth & Income Portfolio | 5.57% | 153,628 | 74.39M | Sep 29, 2026 |
| CALAMOS INVESTMENT TRUST/IL-Calamos Market Neutral Income Fund | 3.62% | 100,000 | 48.42M | Jul 30, 2026 |
| Fidelity Hastings Street Trust-Fidelity Series Large Cap Stock Fund | 3.16% | 87,200 | 42.22M | Sep 29, 2026 |
| VanEck ETF Trust-VanEck Preferred Securities ex Financials ETF | 2.54% | 70,055 | 33.92M | Sep 29, 2026 |